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Neuropathy is the most common neurological consequence of uremia and has the scarce symptoms 
and definition. Therefore the sensitivity/specificity of clinical scores the neuropathy symptom score 
(NSS) and the neuropathy disability score (NDS) were evaluated for uremic neuropathy in the present 
study. 38 hemodialysis patients (23 males, 15 females) and 15 age-sex matched healthy subjects were 
enrolled. Neurological interrogation and examination of the subjects has been performed before 
neurophysiological examinations. After the usual 2 days interval in dialysis, electrophysiological 
studies (EPS) have been performed. Before the EPS, blood samples has been taken before a midweek 
dialysis; hemoglobin, Hct, and albumin concentrations were measured. The Kt/V value was taken as the 
average of previous 12 sessions Kt/V values. The mean NSS was 1.66 ± 2.2, mean NDS was 5.02 ± 6.9 in 
the patient group. According to EPS, 25 patients (65.8%) were diagnosed as having neuropathy [Np (+)] 
and 13 (34.2%) were normal [Np (-)]. The mean values of median, sural nerve sensory, common peroneal 
and posterior tibial nerve motor conduction velocities were lower in the patient group compared to 
controls. Np (+) patients was older than that of Np (-) subjects (50.1 ± 13.8 versus 36 ± 13.6; p = 0.006). 
Age was the only significant predictor of neuropathy (OR = 1.08, 95% CI, 1.017 to 1.150; p = 0.013). 
Logistic regression analysis revealed that both NSS (OR = 2.651, 95% CI, 1.1 to 6.4; p = 0.03) and NDS 
(OR = 1.26, 95% CI, 1.001 to 1.6; p = 0.049) were significantly associated with increased risk of 
neuropathy. The current study showed that both NSS and NDS are sensitive and specific in the 
diagnosis of uremic neuropathy and could be used at least as a first step before turn towards the 
elecrophysiologic studies. 
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Neuropathy is the most common neurological con-
sequence of uremia, occurring in at least 60% of patients 
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The prevalence of clinical signs of polyneuropathy in 
patients undergoing hemodialysis has ranged between 
10 and 83%, with larger series in the range of 50 to 60% 
(Bolton and Young, 1990). Using electrophysiologic 
studies as a more sensitive index, the prevalence of poly-
neuropathy has been somewhat higher, ranging from 57 
to 100% (Dyck et al., 1995). Symptoms of uremic 
polyneuropathy are restless legs, cramps, weakness, pa-





1971). The earliest signs of neuropathy are impaired 
vibratory sensation in the lower limb and loss of tendon 
reflexes, first the Achilles and then the patellar responses. 
Other signs are muscle atrophy, weakness and 
hypoesthesia. Sensory loss develops two-point 
discrimination, position sensation and light touch, pain 
and temperature sensation (Tyler, 1968; Bolton, 1976).  
In routine clinical practice, the scarce symptoms defi-
nition and recording cause some problems in the defining 
and following process of the subjects. The quantitative 
scoring system for neuropathy symptoms and also 
examinations can be more beneficial in this aspect.  
The electrophysiologic features of uremic neuropathy 
include prolonged distal motor latencies, conduction 
velocity slowing, and declines in the amplitudes of com-
pound muscle action potentials (CMAPs) and sensory 
nerve action potential amplitude (SNAPs) (Bolton and 
Young, 1990; Nielsen, 1974). Although there is lot of 
electrophysiological study of uremic neuropathy, optimum 
methodological process and the real contributions of long 
latency reflexes (that is, F response, H reflexes) are also 
unclear (Ackil et al., 1981; Panayitopoulos et al., 1977). 
Slowed nerve conduction velocity (especially sural nerve 
in the early phase) is frequent in uremic patients without 
other symptoms or signs of neuropathy. Although there 
are some suggestive data about the contributions of late 
responses in the process, the correlation between motor 
nerve conduction studies and late responses are not 
clearly reported (Ackil et al., 1981). 
In spite of some studies suggested, a negative cor-
relation existed between serum creatinine elevation and 
decreased velocity of motor nerve conduction (Jebsen et 
al., 1967; Nielsen, 1973; Ackil et al., 1981). There is also 
conflicting evidence in the relationship between the 
severity of neuropathy and age, gender, biochemical 
variables and type of renal disease (Dyck et al., 1995). 
The neuropathy generally evolves over several months 
but on occasion follows a fulminate course (Ropper, 
1973). The factors that determine these differences in the 
clinical course of the neuropathy and the optimum 
method for the follow-up process are unclear.  
Peripheral neuropathy has a high prevalence in 
diabetic patients also (Dyck et al., 1993). Objective and 
quantified measures of diabetic neuropathy are 
recommended in the follow up of disease and for epide-
miological studies or therapeutic trials (Diabetes Care, 
1992). Clinical scores have been developed and vali-
dated to quantify the severity of neuropathy such as the 
neuropathy symptom score (NSS) and the neuropathy 
disability score (NDS) in patients with diabetic neuropathy 
(Dyck, 1988, 1985). Significant associations between both 
NSS and NDS and some individual variables in nerve 
conduction studies were reported in diabetic neuropathy 
(Dyck, 1985). A combined index of polyneuropathy 
derived from nerve conduction studies was found to be 
well correlated with both NSS and NDS in diabetic sub- jects 
also (Feki and Lefaucheur, 2001). However clinical 
applicability and reliability  of  those  clinical  scoring  sys-  




tems in uraemic patients is not extensively studied. 
In the present work, our aim was to investigate perip-
heral nervous system abnormalities in the light of clinical 
scoring systems and broad electrodiagnostic surveys, to 
correlate demographic, laboratory and clinical data with 
the objective and subjective determinants of neuropathy 
in hemodialysis patients. Furthermore, we investigated 
the contributions of quantitative neurological scoring 
systems (NSS and NDS) when neuro-physiological 
diagnosis is accepted as the gold standard.  
 
 
PATIENTS AND METHODS 
 
Patients and clinical evaluation 
 
We studied 38 patients undergoing chronic maintenance 
hemodialysis treatment two or three times weekly, for 3 to 5 h per 
session. The mean length of hemodialysis treatment before the 
study protocol was 4.5 ± 2.3 years (range: 1 to 11 years). The 
etiology of uremia was as follows; atherosclerosis in 12 patients 
(31.6%), polycystic renal disease, interstitial nephritis or glomerulo-
nephritis in 9 patients (23.7%), obstructive nephropathies in 4 
patients (10.5%) and other etiologies in 5 patients (13.2%). The real 
etiology of renal failure in 8 patients (21%) was not known. All the 
patients were taking medications including calcium containing 
phosphate binders, a standard B+C vitamin complex pill after 
dialysis session, oral or intravenous iron supplementation and 
erythropoietin alpha/beta 4000 to 5000 IU subcutaneous 1 to 3 
times in a week, to stabilize hemoglobin levels > 10.5 gr/dl. Patients 
with other possible causes of neuropathy such as diabetes mellitus, 
alcoholism, amyloidosis, or other systemic causes were excluded 
from the study. All patients gave written informed consent for the 
study protocol and detailed explanation has been made according 
to Helsinki declaration.  
Neurological interrogation and examination of the subjects has 
been performed before neurophysiological examinations. After the 
usual 2 days interval in dialysis, electrophysiological measurements 
have been performed. Before the electrophysiological investigations, 
blood samples have been taken before (fasting) a midweek dialysis 
session; hemoglobin, hematocrit, and albumin concentrations were 
measured using appropriate biochemical methods. The Kt/V is 
defined as dialyzer urea clearance (K), multiplied by the dialysis 
session length (t), divided by the urea distribution volume (V) 
(Basile et al., 1990). Kt/V value was taken as the average of 
previous 4 weeks (12 sessions) Kt/V values per session. 
The major symptoms encountered in peripheral neuropathy are 
listed in the neurological symptom score (NSS) developed by Dyck 
et al. (1999) specifically for diabetic neuropathy; where a total of 18 
points. (1) Symptoms of muscle weakness (bulbar/limbs), (2) 
sensory disturbance [(negative/positive symptoms), autonomic 
symptoms] are questioned and the presence of each symptom is 
considered as 1 point to reach a maximum total 18 points. 
Neurological impairments of the subjects has been calculated using 
neuropathy impairment score (NIS) developed by Dyck et al. (1995) 
after the neurological disability score for the specific follow-up of 
neuropathy patients. Where neuropathic deficits for cranial nerves 
(3rd nerve, 6th nerve, facial weakness, palate weakness, and 
tongue weakness) were examined and scored as 1 point for each of 
them. Muscle weakness is scored: normal = 0; 25% weak = 1; 50% 
weak = 2; 75% weak = 3; and paralyzed = 4 for 18 separate joints 
handled by the different muscle groups. Respiratory muscle weak-
ness is scored as present = 1, absent = 0. Reflexes were graded as 
normal = 0, decreased = 1, or absent = 2 (Nielsen et al, 1972).  
Touch-pressure, pinprick and vibration are assessed on the 
dorsal surface of the terminal phalanx of index finger and  great  toe 




Table 1. Demographic characteristics of patient and control groups. 
 
Parameter Patient (n = 38) Control (n = 15) p 
Age 45.7±15.1 41±12 NS 
Sex 23M/15F 11M/4F 0.04 
Time on dialysis 4.5±2.3 - - 
BUN 96.4±29.1 - - 
Creatinine 4.1±1.7 - - 
Albumine 3.8±0.96 - - 
NSS 1.7±2.2 - - 
NDS- total  20±5.2 - - 




and were graded as normal = 0, decreased = 1, or absent = 2. 
Right and left extremities are scored separately and total score 
were calculated as the sum of the right and left sides, the highest 
possible score being 208. This score has been recommended to 
use extensively in medical practice simply to worsening or improve-
ment of neuropathies. Total score has been calculated for each 
subject and used in the statistical analysis.  
 
 
Nerve conduction studies 
 
The whole neurophysiologic measurements were done using 
Medelec Synergy EMG Equipment (Medelec-Oxford, England) and 
appropriate analysis programs. The temperature of the extremities 
kept at least 29°C. If they were cooler, the limbs were warmed. The 
motor and sensory nerve conduction studies have been performed 
from each extremity of the subjects except if the extremity has 
arteriovenous (AV) fistula for hemodialysis. The motor nerve con-
duction velocity, distal motor latency, and CMAP amplitude of the 
median, ulnar (one side), peroneal and posterior tibial nerves (two 
side) were measured. The F-wave minimal, mean and maximal 
latencies and chronodispersion of F-waves were studied after 10 
supramaximal stimuli. The sensory nerve conduction velocity and 
SNAP of median, ulnar (one side) and sural (two side) nerves were 
measured. The exact details of the methods for each nerve have 
been described elsewhere (Flack B-1991, EMG yöntem kitabı). 
Electrophysiological values of patients were compared with those of 
control group. Values exceeding the mean ± 3 standard deviation 





The results of descriptive analyses were tested and found  to  show 
normal distribution, thus data were given as the means and 
standard deviations. Parametric data were compared using 
unpaired t test and nonparametric data were compared using the χ
2
 
 or Fisher exact tests. The correlations between the neuropathy, 
quantitative neurological scoring and the biochemical or demogra-
phic variables were determined using appropriate statistics. Binary 
logistic regression analysis was  used  to  determine  the  predictive 
factors including NSS and NDS for neuropathy development.  
The sensitivity, specificity, and positive predictive value (PPV) 
were calculated for NSS and NDS using ROC-curve analysis and 
the electrophysiological neuropathy diagnosis as the gold standard. 
Sensitivity here refers to the proportion of patients with these NSS 
or NDS abnormality who meet the neuropathy diagnosis. Specificity 
refers to the proportion of patients who do not have these NSS or 
NDS abnormality and who did not meet the neuropathy diagnosis. 
PPV refers to the proportion of patients with the NSS or NDS 
abnormalities who actually have the disease. Significant differences 
(two-tailed p) less than 0.05 were regarded as significant. Neural 
network analysis was performed to determine the sensitivity, 
specificity and the cut off values of NDS and NSS for differentiation 
of polyneuropathy types including motor or sensory or mixed poly-
neuropathy. Radial basis function was used for the classification of 
neuropathy types according to NDS score due to having better 





The mean age of our patients was 44.4 ± 14.3 years 
(from 21 to 75 years) and males were predominating 
(61%, 23 patients). Fifteen volunteers have been inter-
viewed as control subjects. Similar to the patient group, 
males were predominating (73%, 11 subjects) in the 
control group. The mean age of the control subjects was 
41.1 ± 12.02 years (from 26 to 67 years). According to 
selection criteria, groups were comparable for age and 
gender. Demographic features of the study and control 
groups have been shown in Table 1.  
The mean NSS score was 1.66 ± 2.2 (0 to 8) and the 
mean NDS score was 5.02 ± 6.9 (0 to 20). There was a 
strong positive correlation between NSS and NDS results 
(r = 0.844; p = 0.001). NSS and NDS examinations 
revealed superficial sensory loss in 4 patients (10.5%), 
deep sensory loss in 7 patients (18.4%), abnormality in 
deep tendon reflexes in 9 patients  (23.7%), trophic 
defect in 3 patients (7.8%) and autonomic defect in 1 
patient (2.6%). Electropyhsiologic study (EPS) results 
showed that the mean values of median and sural nerve 
sensory, common peroneal and posterior tibial nerve 
motor conduction velocities were lower in the patient 
group compared to controls. However, ulnar sensory and 
motor conduction velocities were similar between patient 
and control groups. 
Median motor distal latency was longer in patients 
compared to control subjects. Except for posterior tibial 
nerve, all motor nerve amplitudes studied were shown to 
be decreased in patient group compared to controls. 
Minimum F wave latencies and F wave chronodispersion 
values were not different between patient and control 
groups (Table 2) while the EPS results of each of the 




Table 2. Comparison of the values in nerve conduction studies between patient and control groups. 
 
Parameter Patient (n = 38) Control (n = 15) p 
Median sensory  conduction velocity  52.1±5.5 56.2±3.8 0.011 
Ulnar sensory  conduction velocity 52.6±4.8 54.3±2.7 0.113 
Sensory distal latency difference of median and ulnar nerves recorded IVth digit 0.3±0.02 0.2±1.12 0.02 
Median motor distal latency 3.9±0.6 3.4±0.3 0.000 
Median motor  conduction velocity 54.2±4.5 54.2±4.5 0.985 
Median motor  amplitude 7.0±3.2 9.6±3.5 0.014 
Ulnar motor conduction velocity 57.0±4.9 57.8±6.1 0.619 
Ulnar motor  amplitude 8.3±2.2 10.2±1.7 0.005 
Common peroneal motor conduction velocity 40.8±7.2 46.7±3.4 0.004 
Common peroneal motor amplitude 3.2±2.0 4.6±1.7 0.02 
Posterior tibial motor conduction velocity 37.3±4.2 43.6±2.8 0.000 
Posterior tibial motor amplitude 5.7±2.5 7.3±2.6 0.051 
Sural sensory  conduction velocity 32.5±18.7 44.4±4.3 0.001 
Median F min 27.5±2.5 26.3±1.6 0.08 
Median F chronodispersion 2.3±1.0 2.7±1.4 0.323 
Ulnar F min 28.7±3.3 27.9±2.2 0.411 
Ulnar F chronodispersion 1.7±0.9 1.9±0.8 0.47 
Tibial F min 52.2±9.0 48.2±4.7 0.11 




patients compared with the mean values of 
normal controls separately; 3 patients (7.8%) 
showed a decrease in median nerve conduction 
velocity, 7 patients (18.4%) showed a decrease in 
sural nerve conduction velocity, 3 patients (7.8%) 
had decreased peroneal BKAP amplitudes, 3 
patients (7.8%) had decreased common peroneal 
conduction velocity, 9 patients (23.7%) had 
decreased tibial nerve conduction velocity, 11 
patients (28.9%) showed an extended median 
nerve F wave latency. Ulnar F wave latency was 
extended in 11 (28.9%) and tibial F wave latency 
was extended in 12 (31.6%) patients. 
According to those results, 25  patients  (65.8%)  
were diagnosed as having neuropathy [Np (+)] 
and 13 (34.2%) were normal [Np (-)]. Among the 
Np (+) patients, 5 patients (20%) had sensory 
neuropathy, 1 patient (4%) had motor neuropathy 
and 19 patients (76%) had mixed neuropathy. 
Entrapment of the median nerve in carpal tunnel 
(Carpal Tunnel Syndrome) was observed in 11 
patients (28.9%). Np (+) patients was older than 
that of Np (-) subjects (50.1 ± 13.8 versus 36 ± 
13.6; p = 0.006). Haemoglobin, hematocrit (%), 
serum albumin, kt/V and time on dialysis values 
were similar between Np (+) and Np (-) patients. 
Np (+) patients had significantly higher NSS and 
NDS scores than that of Np (-) subjects (Table 3). 
Logistic regression analysis revealed that both 
NSS (OR = 2.651, 95% CI, 1.1 to 6.4: p = 0.03) 
and NDS (OR = 1.26, 95% CI, 1.001 to 1.6; p = 
0.049) were significantly associated with risk of 
neuropathy. The determinative values for the 
occurrence neuropathy in NSS and NDS were as 
follows: for NSS = 0.5 [Se = 0.654, Sp = 0.667; p 
= 0.014, positive predictive value (ppv): 81%, 
negative predictive value (npv): 47.1%], for NDS = 
1.5 (Se = 0.538, Sp = 0.833; p = 0.033, ppv = 
87.5%, npv = 45.5%), (Figure 1). A logistic 
regression analysis performed on the possible 
predictive factors (age, time on dialysis, Kt/V, 
hemoglobin, albumin for neuropathy  showed  that 




Table 3. Comparison of demographic features, laboratory analyses, NSS 
and NDS scores between Np (+) and Np (-) patients. 
 
Parameter Np (+) Np (-) p 
Age 50.1±13.8 36 ±13.6 0.006 
Sex (male/female) 16/9 8/5 NS 
Time on dialysis 4.6±2.4 4.3±2.1 NS 
Hb 8.3±1.4 7.8±1.3 NS 
Hct 28.2±1.8 27.3±3.7 NS 
Albumin 3.6±0.9 4.1±0.9 NS 
Kt/v 1.27±0.04 1.28± 0.05 NS 
NSS 2.3±2.2 0.3±0.5 0.008 
NDS 6.9±7.6 0.8±1.9 0.009 
 









Mixed PNP Absence of PNP Motor PNP Sensory PNP 
Total 19.0 13.0 1.0 5.0 
Correct 11.0 13.0 0.0 0.0 
Wrong 8.0 0.0 1.0 5.0 
Unknown 0.0 0.0 0.0 0.0 
Correct (%) 57.9 100.0 0.0 0.0 
Wrong (%) 42.1 0.0 100.0 100.0 




the age was only a significant predictor of neuropathy 
(OR: 1.08, 95% CI, 1.017 to 1.150; p = 0.013). 
Neural network analysis revealed that the NDS was the 
most sensitive test for discrimination of neuropathy types 
sensory, motor or mixed. However, NSS was neither 
sensitive nor specific for the classification of neuropathy 
types. Radial basis function was used for the score due to 
having better performance for this data set classification 
of neuropathy types according to NDS than the other 
models. 58% of the patients with mixed type polyneuro-
pathy and 100% of Np (-) patients have been accurately 
diagnosed using NDS. However, patients with motor or 
sensory polyneuropathy were not correctly diagnosed due 
to low patient numbers in those groups (Table 4). 
Increase in NDS score led to increase in the probability of 
having mixed type polyneuropathy. Patients with a NDS > 
12 had 0.75 probability of having mixed type 
polyneuropathy. Patients with NDS < 7 had a  probability 
between 0.5 to 0.7 to be np (-). The probability of being 
np (-) progressively decreased in patients with NDS > 7 





The present study showed a high prevalence of uremic  
neuropathy (65.8%) according to EPS results that was in 
line with the reports in literature (Zochodne, 2005). Male 
predominance of our patient group may contribute to this 
high prevalence also (Galassi et al., 1998). Neuropathic 
patients were older than non-neuropathic subjects. 
Likewise, Bazzi et al. (1991) reported a more severe 
electrophysiologic impairment of ulnar and sural nerves in 
older hemodialysis patients compared to younger ones. 
They reported a more severe neurologic impairment in 
patients with longest duration of dialysis (more than 10 
years). 
In present study, duration of dialysis, weekly Kt/v, 
hemoglobin, hematocrit and albumin values were not 
different between neuropathic and non-neuropathic 
subjects. However, in our patient group, mean duration of  
dialysis was shorter (4.5 ± 2.3 years) compared to their 
results. Laaksonen et al. (2002) could not find an 
association between occurrence of neuropathy and 
duration or efficiency of dialysis also. Uremic neuropathy 
can affect motor, sensory, autonomic and cranial nerves 
(Galassi et al., 1998); however it clinically presents a 
symmetrical distal sensory loss for all modalities which is 
more  pronounced  in  lower  extremities  (Raskin, 2001).  
In the current study, the most prevalent neuropathy 
type was mixed (sensory + motor) polyneuropathy (76%), 
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Figure 1. ROC-Curve analysis showing sensitivity and specificity of 


















































Figure 2. Confidence response graph showing the determinative 





neuropathies (4%). Although we  did not perform an 
objective test for autonomic neuropathy, NSS results 
determined autonomic defect in 1 patient (2.6%). There is 
no strict definition for a predominant type of neuropathy in 
uremic patients. However, the pathological state uremic 
neuropathy is a multiple neuropathy due to axonal 
degeneration of the sensory and motor nerves, starting 
from the lower extremities with secondary development of 
demyelination (Thomas et al., 1971). Furthermore, as a 
support to our findings, previous studies based on either 
EPS results or quantitative neurologic scoring systems 
revealed the  synchronous  presentation  of  sensory  and  




motor neuropathies in uremic subjects (Laaksonen et al., 
2002; Ogura et al., 2001).  
Original description of uremic neuropathy were made 
by Marin and Tyler (1961) as subacute weakness, distal 
sensory loss to pinprick, cold, light touch, vibration and 
position and loss of deep tendon reflexes. The electro-
physiologic features of uremic neuropathy include 
prolonged distal motor latencies, conduction velocity 
slowing and declines in the amplitudes of CMAPs and 
SNAPs (Bolton and Young, 1990; Nielsen, 1974). Sural 
nerve conduction slowing is suggested to be most 
sensitive electrophysiologic parameter of early polyneuro- 
pathy (Ackil et al., 1981). In agreement with those 
previous findings, our results revealed significant slowing 
of sural sensorial conduction velocities in patient group 
compared to healthy controls.  
Slowing in common peroneal and tibial motor 
conduction velocities, prolongation of median motor distal 
latencies and decrease in motor amplitudes except 
posterior tibial nerve were noticed in patient group 
compared to controls. Although slowing in median 
sensorial conduction velocity is observed, median motor, 
ulnar motor and sensorial conduction velocities were not 
seemed to be affected. That may be due to entrapment of 
the median nerve in carpal tunnel (Carpal Tunnel 
Syndrome/CTS) which was observed in 11 patients 
(28.9%). Significant difference in sensory distal latencies 
of median and ulnar nerves recorded IVth digit was a 
further evidence for important entrapment of median 
nerve in carpal tunnel. It is well known that hemodialysis 
patients are prone to compression of median nerve in 
carpal tunnel secondary to dialysis associated 
amyloidosis or uremic tumoral calcinosis (Gejyo et al., 
1997; Cofan et al., 2002). So, the abnormalities seen in 
the median nerve recordings were probably not caused 
by the polyneuropathy alone. The latencies of ‘’ long 
loop’’ F waves and H reflexes are prolonged in uremic 
neuropathy (Panayitopoulos, 1980, 1977).  
Laaksonen et al. (2002) showed that the F wave 
latencies of the lower extremity nerves were by far the 
single most sensitive neurophysiologic parameter in 
detection of uremic neuropathy. Although comparison of 
mean F wave recordings were not different between our 
patient and control groups, comparison of the patients 
individually with the mean values of control group 
revealed   prolongation  of  F   wave  latencies  in  median  
(11 patients; 28.9%), ulnar (11 patients; 28.9%), and tibial 
(12 patients; 31.6%) nerve recordings. Similar F wave 
latency values between patient and control groups may 
be caused by the low patient number in our study. 
The current study is mainly conducted to evaluate the 
predictive roles of subjective neurologic symptom (NSS) 
and neurologic disability scores (NDS) which are mainly 
validated for diabetic neuropathy (Dyck, 1988)  on  EPS 
results as a gold standard in the diagnosis of uremic 
neuropathy. Both NSS and NDS in our patient group were 
higher than that of controls. Furthermore, both NSS and 
NDS were found to be sensitive and specific  tests  in  de- 




termination of uremic neuropathy. Previously, vibration 
perception threshold (vibrameter testing) was shown to 
be a valid and valuable, simple, quick and non-invasive 
method for evaluation of severity in peripheral uremic 
neuropathy by different authors (Klima et al., 1991). 
Krishnan et al. (2006) reported a significant correlation 
between total NSS and both pre-dialysis subexcitability 
and depolarizing threshold electrotonus. 
Significant correlations between different neuro-
physiologic records (sural conduction velocity and 
amplitude, tibial conduction velocity and amplitude, tibial 
F wave latency) and related local symptoms were 
reported also (Laaksonen et al., 2002). However to our 
knowledge till date, no study evaluated the sensitivity and 
specificity of NSS and NDS in diagnosis of occurrence or 
typing of uremic neuropathy. The present study showed 
that both NSS and NDS were sensitive and specific tests 
in diagnosis of uremic neuropathy. Our results demon-
strated that NDS may also predict the occurrence of 
mixed type polyneuropathy in hemodialysis patients. 
Because of the low patient numbers in motor and sensory 
neuropathy groups, we could not make a comment about 





Uremic polyneuropathy is probably the most common 
complication of chronic renal failure and affect the 
significant proportion of the hemodialysis patients. To 
date, there is no universally accepted approach to the 
diagnosis and the management of neuropathy in 
hemodialysis patients. Although EPS is the gold standard 
for the diagnosis of neuropathy, it is time consuming and 
not feasible for all the patients. Both NSS and NDS are 
simple, quick and practicable tests and could be 
applicable to hemodialysis patients with regular intervals. 
The current study demonstrated that both NSS and NDS 
are sensitive and specific in the diagnosis of uremic  
neuropathy and could be used at least as a first step 





OR, Odds ratio; EPS, electropyhsiologic study; Se, 
sensitivity; Sp, specificity; ROC, receiver operating 
characteristic; BUN, blood urea nitrogen; NSS, neuro-
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